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Abstract
Background: Respiratory syncytial virus (RSV) infects nearly all infants by age 2 and is a leading cause of bronchiolitis. RSV
may employ several mechanisms to induce immune dysregulation, including dendritic cell (DC) modulation during the
immune response to RSV.
Methods and Findings: Expansion of cDC and pDC by Flt3L treatment promoted an anti-viral response with reduced
pathophysiology characterized by decreased airway hyperreactivity, reduced Th2 cytokines, increased Th1 cytokines, and a
reduction in airway inflammation and mucus overexpression. These protective aspects of DC expansion could be
completely reversed by depleting pDCs during the RSV infection. Expansion of DCs by Flt3L treatment enhanced in CD8+ T
cell responses, which was reversed by depletion of pDC.
Conclusions: These results indicate that a balance between cDC and pDC in the lung and its lymph nodes is crucial for the
outcome of a pulmonary infection. Increased pDC numbers induced by Flt3L treatment have a protective impact on the
nature of the overall immune environment.
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Introduction
Respiratory syncytial virus (RSV) infects nearly all infants by
age 2 and is the leading cause of bronchiolitis in children
worldwide. It is estimated by the CDC that up to 125,000
pediatric hospitalizations in the United States each year are due to
RSV, at an annual cost of over $300,000,000 [1]. While RSV is
especially detrimental in very young infants whose airways are
small and easily occluded, RSV is also widely becoming
recognized as an important pathogen in the elderly, transplant
recipients, patients with chronic obstructive pulmonary disease
(COPD), as well as chronic asthmatics [2]. Despite the generation
of RSV-specific adaptive immune responses, RSV does not confer
protective immunity and recurrent infections throughout life are
common [3]. This suggests that RSV may employ several
mechanisms to induce immune dysregulation, illustrated by the
failure of a vaccine to RSV in the 609s [4]. It has been suggested
that the nature of the immune response is dependent upon the
characteristics of the innate immune system and APC function.
Our present study was aimed at determining whether the balance
of DC subsets or the merely increased numbers of DCs were the
key to effective anti-viral immune responses.
Two major DCs subsets in the mouse are CD11b+, CD11c+
myeloid/conventional DC (mDC/cDC) and CD11b-, B220+
plasmacytoid DC (pDC) [5]. A series of studies have outlined
distinct differences in the ability of DC subsets to induce immune
responses. In particular, cDC have been implicated in driving a
pro-allergic response, while pDC have been identified to block or
‘‘tolerize’’ the pulmonary immune environment against Th2
responses [6]. Other data have identified that pDC can participate
or functionally mediate anti-viral responses in the lung, either
directly by secretion of IFN-a or indirectly through activation of
other cell populations [7,8]. Previously, it was demonstrated that
treating animals with recombinant Flt3 ligand (FLt3L) increased
numbers of cDC and pDC in circulation as well as in peripheral
organs, which can protect animals from metastatic tumor
development and prolong survival, and reverse late stage allergic
responses in the lung [9–13]. Previous results from our laboratory
have indicated that depletion of pDC from the lungs of RSV-
infected mice results in a more pathologic response with increased
AHR, mucus, and Th2 cytokine profile [14]. In the present study
we used Flt3L treatment in vivo before RSV infection to increase
the numbers of both cDC and pDC to facilitate enhanced innate
immune responses. Coupled with pDC depletion, we have been
able to establish a differential role of cDC and pDC for
maintenance of the appropriate anti-viral pulmonary immune
environment. Although we were able to maintain cDC numbers
upon pDC depletion, this increase was not able to maintain the
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enhanced anti-viral pulmonary environment, rather it increased
the severity of the pathophysiologic responses. Thus, these studies
further establish the differential roles of pDC and cDC subsets
within the lung during viral infections.
Materials and Methods
Animals
Female BALB/cByJ mice, 6–8 weeks of age, were obtained
from the Jackson laboratory. All mice were housed under specific
pathogen-free conditions within the animal care facility at the
University of Michigan. The University of Michigan Committee
on the Use and Care of Animals approved all experiments.
Culture and stimulation of mouse and human cDC and
pDC
For culture of pDC and cDC, mouse bone marrow was isolated
and cultured with Flt3L (200 ng/ml, Amgen) or with GM-CSF
(10 ng/ml, R&D) respectively, as previously described [15] [16].
Plasmacytoid DC were isolated from the Flt3L culture after 9 days
using a MACS bead pDC isolation kit (Miltenyi) or by cell sorting
for CD11c+/B220+ cells. After isolation, cells were stimulated with
RSV (MOI of 2) for 24 h. Cells were stained with the following
antibodies: anti-mouse I-Ab, CD86, CD80, CD40, (BD Pharmin-
gen). Supernatants were frozen until further analysis.
Expansion of DC, RSV infection model and RSV plaque
assay
Mice were treated with human Flt3L (kindly provided by Amgen,
Seattle, USA) for 10 consecutive days to expand DC in vivo, as
described before [9]. RSV subtype A, Umich/line 19 strain was
derived from a clinical isolate at the University of Michigan and was
propagated in Hep2 cells. Infection was allowed to proceed until
syncytia were observed. Then, cells were frozen at 280uC and the
supernatants were harvested, clarified, and aliquoted. This RSV
preparation was tested negative for both endotoxin and mycoplas-
ma. To determine viral titers in culture supernatants and lung
homogenates, an immunoplaque assay was performed as previously
described [14]. For RSV infection, mice were anesthetized with
ketamine/xylazine and intratracheally infected with ,16105 PFU
of RSV. Administration of UV irradiated RSV does not elicit any
responses in the lungs in mice, demonstrating no confounding effects
of the medium used to culture RSV in vivo. Plasmacytoid DC were
depleted in vivo by i.p. injecting mice 1 day before and 1 and 3 days
after RSV infection with 150 mg 120G8 antibody as described before
[14]. All control and RSV-infected mice received an isotype control
antibody (rat IgG, Sigma).
Assessment of lung pathology
Eight days after RSV infection, airway reactivity in anesthetized
mice was measured as previously described [14,17–20]. For this
purpose, mice were anesthetized with sodium pentobarbital, the
trachea was cannulated and ventilated using a pump ventilator.
After baseline measurements, mice were injected i.v. with 2.5 mg
of methacholine (125 mg/kg; Sigma-Aldrich) and the peak airway
resistance was recorded. The optimal dose was determined in
uninfected mice using single increasing doses of methacholine in
different mice to choose the highest dose that gave little
responsiveness. This dose was then used in RSV infected mice
in the remainder of the mice, as previously described.
Lungs were inflated and maintained in formalin for 24 h before
being processed into paraffin using standard histological tech-
niques. Lung tissue sections were stained with hematoxylin and
eosin (H&E) for analysis of inflammatory cell accumulation and
alcian blue/periodic acid-Schiff for assessment of mucus produc-
tion. To quantify the mucus production in the lung, PAS sections
were randomized and examined and scored on a scale from 1 to 4,
with 1 representing no mucus cell content and 4 representing
airways filled with mucus.
Single cells suspensions of lung draining lymph nodes were
prepared by isolation of mediastinal lymph nodes, pushing cells
trough a nylon mesh using a syringe and lysis of red blood cells. Cells
were cultured in RPMI medium (RPMI 1640 with 10% FCS, L-
glutamine and Pen/Strep) at a concentration of 56106 cells/ml in the
presence of either plate bound anti-CD3 (10 mg/ml, Pharmingen) or
medium alone and incubated at 37uC. After 3 days, supernatants
were collected and stored at 280uC until further analysis.
Six days after RSV infection, RNA was isolated from lungs
using TRIZOL reagent (Invitrogen), according to the instructions
of the manufacturer. Each sample was reverse transcribed into
cDNA and analyzed by quantitative real-time PCR using Taqman
(Applied Biosystems). Raw data were normalized to GAPDH
control standards in each sample.
Commercially available Biorad X-plex kits (using luminex
technology) were used measure cytokine and chemokine levels in
culture supernatants. Mouse IFN-a was measured using a
commercial ELISA kit from PBL Biomedical Laboratories which
has a detection limit of 13 pg/ml.
Flow cytometry of lungs and lymph nodes
Lungs and lung draining mediastinal lymph nodes were isolated
and dispersed using 0.2% collagenase (Type IV, Sigma-Aldrich) in
RPMI with 10% FCS at 37uC for 45 minutes. After lysis of red
blood cells and blocking non-specific binding by FcR, cells were
counted and stained with antibodies or isotype controls. The
following antibodies were used: anti-CD3, anti-CD4, anti-CD8,
anti-CD11c, anti-B220, anti-CD11b, anti-CD69 (Pharmingen)
and RSV M2 82-90 peptide pentamer (Proimmune). Cells were
fixed with paraformaldehyde (1%, overnight) and kept in the dark
at 4uC until analysis on a Cytomics FC500 flow cytometer
(Beckman-Coulter). For intracellular cytokine staining, lung cell
suspensions were cultured at a concentration of 106 cells/ml
medium in 24 well plates for 4 h in the presence of PMA (50 ng/
ml), ionomycin (500 ng/ml) (Sigma) and Golgi stop (1 ml/ml,
Becton Dickinson). Following fixation and permeabilization, cells
were stained with anti-IFN-c (Pharmingen) or isotype control.
Statistical analysis
Differences between groups were analyzed by using one-way
ANOVA with a bonferrroni post-hoc test. With a p value of
,0.05, differences were considered significant.
Results
RSV infection induces differential responses in pDC and
cDC
Because cDC and pDC populations have been implicated in
anti-viral responses, our initial studies examined the differential
expression of immune mediators after RSV infection. Using
isolated cDC (CD11b+/CD11c+) and pDC (B220/CD11c+)
populations cultured from bone marrow of naive mice various
cytokines were measured after RSV infection (MOI = 2.0). The
data presented in Figure 1A demonstrate that the two DC subsets
differentially produced cytokines in response to a RSV infection.
Conventional DC produced IL-10, IL-12, IL-6 and CxCL-10 with
no detectable IFN-a, while the pDC produced high levels of IFN-
a, lower levels than cDC of IL-6, CxCL10 and no detectable levels
pDC Dictates Immunity to RSV
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of IL-10 and IL-12. Both DC subsets were able to produce similar
levels of TNF-a and CCL2. When activation markers were
examined by flow cytometry, there were also significant differences
in the increase in expression of costimulatory markers, CD80 and
CD86, as the pDC more significantly upregulated those two
molecules compared to the cDC subset (Figure 1B). Both subsets
similarly upregulated class II and CD40 after RSV infection.
Selective expansion of the number of cDC and pDC in
the lung by Flt3L treatment and 120G8
We subsequently studied the functional role for cDC and pDC
in vivo. Our previously published data demonstrated that by
depletion of the pDC subset we were able to significantly alter the
immune response to RSV in vivo [14]. Now, studies were designed
to extend those earlier observations in order to better define the
role of the individual subsets of DC during the pulmonary immune
response. To expand the number of pDC and cDC in vivo, mice
were treated with Flt3L for 10 days as previously described [11].
Lungs and lung draining lymph nodes were analyzed after this
treatment for the presence of CD11chigh/CD11bhigh cDC or
CD11c+/B220+, pDC (Figure 2). These data show that Flt3L
treatment dramatically increased the number of both pDC and
cDC in the lung and lung draining lymph nodes of naı¨ve,
Figure 1. Differential activation profiles of pDC and cDC by
RSV. Bone marrow from BALB/c mice was cultured with Flt3L or GM-
CSF for preferential expansion of pDC and cDC, respectively, as
described. Isolated cell populations (1.106/ml) were subjected to RSV
infection (MOI-2.0) for 24 hrs and the supernatants and cells were
collected to assess cytokine levels by luminex (A) and surface activation
markers by flow cytometry (B). The mean fluorescent intensity (MFI)
was assessed using the entire cell population in control vs. RSV-infected
cells. The data represent mean6SEM of 4 repeat experiments.
doi:10.1371/journal.pone.0001720.g001
Figure 2. Selective expansion of cDC and pDC in the lung and
the lung draining lymph nodes by Flt3L and 120G8 treatment.
After Flt3L and 120G8 treatment, lung and lung lymph node cell
suspensions from control, Flt3L treated (Flt3L) and pDC depleted Flt3L
treated (Flt3L+120G8) mice were analyzed by flow cytometry for the
presence of pDC and cDC (mDC). Numbers indicate the percentage of
total cells in the gate shown. Shown are the representative flow plots of
3 experiments (A). The mean6SE from all of the mice in 3 experiments
demonstrates that only pDC have been depleted in the lung and lymph
node (LN) with the 120G8 (B).
doi:10.1371/journal.pone.0001720.g002
pDC Dictates Immunity to RSV
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uninfected mice. To study the impact of increased numbers of
cDC on subsequent development of RSV responses, mice with
Flt3L treatment were given the pDC-depleting antibody 120G8,
which inhibited the increase of pDC but not cDC. Although this
antibody did not completely remove all pDCs, the treatment
significantly reduced pDC numbers while allowing the increased
numbers of cDC to be maintained. No effect of Flt3L treatment or
pDC depletion was observed on the number of CD4+, CD8+ T
cells, DX5+ NK cells or CD19+ B cells in the lungs of naı¨ve mice
(data not shown). The combined data from all of the treated mice
is summarized in Figure 2B and confirms that 120G8 significantly
reduces only pDC and not cDC subsets. Conclusively, this
protocol provides an avenue for investigating whether increased
pDC or cDC numbers could modulate the response to RSV.
DC expansion attenuates RSV-induced
immunopathology, dependent upon pDC
We next investigated whether the selective expansion of cDC and
pDC, or cDC alone, affected manifestations of RSV-induced
immunopathology in the lung. RSV-infected mice developed airway
hyperreactivity, as measured by a strong increase in airway resistance
in response to methacholine compared with control mice on day 9
(Figure 3A). Expansion of both cDC and pDC by Flt3L diminished
this airway hyperreactivity. In contrast, expansion of cDC alone
significantly enhanced the airway hyperreactivity induced by RSV.
Next, we studied effects of DC expansion on the cytokine
environment in the lung draining lymph nodes and the lung itself.
RSV infection enhanced production of both the Th1 cytokine IFN-c
and the Th2 type cytokines, IL-4, IL-5, and IL-13 by lymph node T
cells after restimulation compared to naı¨ve mice (Figure 3B).
Expansion of both cDC and pDC significantly inhibited IL-4, IL-5
and IL-13 production, but enhanced IFN-c production. In contrast,
when pDC were depleted a significant enhanced IL-4, IL-5 and IL-
13 production was observed, while IFN-c production remained the
same as in the RSV control animals. In order to analyze cytokine
expression in the lung, real-time PCR analysis of the lung showed
that RSV infection elicited transcription of IL-4, IL-13 and IFN-c in
the lung (Figure 2C). Again, expansion of both DC subtypes lowered
transcription of IL-4 and IL-13 and enhanced IFN-c, while
expansion of cDC alone significantly enhanced the transcription of
IL-4 and IL-13 and lowered IFN-c expression to normal levels. In
addition, analysis of expression of RSV G protein in the lung showed
that expansion of cDC and pDC inhibited expression of RSV in the
lung, while expansion of only cDC significantly enhanced expression
of RSV (Figure 3C).
Histological examination of control mice showed that RSV
infection leads to a peribronchial and perivascular inflammatory
infiltrate consisting of mononuclear cells and leads to goblet cell
hyperplasia and mucus production in the lung (Figure 4A). After
expansion of cDC and pDC animals appeared less inflamed and
Figure 3. Selective expansion of cDC and pDC affects RSV-
induced airway hyperresponsiveness and immunological re-
sponses in the lung. (A) Eight days after RSV infection, airway
responses were measured in control (cont), RSV-infected (RSV), Flt3L
treated and RSV-infected (Flt3L+RSV) and Flt3L treated, pDC depleted,
RSV infected (Flt3L+120G8+RSV) mice after one dose of methacholine
(125 mg/kg) and compared to basal measurements. Data are repre-
sented as mean airway resistance in cm H2O/ml/sec6SEM. (B) Lung
lymph node T cell cytokine production in response to anti-CD3
stimulation. Eight days after infection, lung lymph nodes were isolated
from control (Cont), RSV-infected (RSV), Flt3L treated and RSV-infected
(Flt3L+RSV) and Flt3L treated, pDC depleted, RSV infected
(Flt3L+120G8+RSV) mice and stimulated with anti-CD3 at a concentra-
r
tion of 56106 cells/ml. Data are represented as mean ng/ml6SEM. (C)
Cytokine messenger RNA levels in the lungs of mice. Six days after
infection, mRNA was isolated from lungs of control (Cont), RSV-infected
(RSV), Flt3L treated and RSV-infected (Flt3L+RSV) and Flt3L treated, pDC
depleted, RSV infected (Flt3L+120G8+RSV) mice and analyzed using
quantitative real-time PCR by Taqman. Each sample was normalized
using a GAPDH control and the data show average fold increase to
control6SEM. * P,0.01 compared to non-infected control mice, #
P,0.05 compared to RSV infected mice, n = 5 mice per group. This
experiment was repeated twice with similar numbers of mice and
displayed comparable results.
doi:10.1371/journal.pone.0001720.g003
pDC Dictates Immunity to RSV
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displayed much less intense goblet cell hyper/metaplasia
(Figure 4B), as assessed using a blinded subjective scoring system.
Assessing 2 mucus-associated genes, muc5ac and gob5 supported
the subjective scoring analysis showing a decrease in the expression
of both genes after expansion of cDC and pDC but an increase
after pDC depletion (Figure 4B).
Modulation of the number of cDC and pDC in the lung
after RSV infection by Flt3L and the 120G8 antibody
We next investigated whether the selective expansion of DC was
maintained in the lung and lung lymph nodes throughout
infection. Six days after infection with RSV, numbers of both
cDC and pDC were increased in both lungs and lymph nodes
Figure 4. RSV induced-inflammation and mucus production in the lung is affected by selective expansion of cDC and pDC. (A) Eight
days after infection, lung sections were stained with H&E and PAS. Shown are representative sections of control (Cont), RSV-infected (RSV), Flt3L
treated and RSV-infected (Flt3L+RSV) and Flt3L treated, pDC depleted, RSV infected (Flt3L+120G8+RSV) mice in a 2006 (H&E) or 4006 (PAS)
magnification. (B) To quantify the mucus production in the lung, PAS sections were randomized, examined in a blinded fashion and scored on a scale
from 1 to 4, with 1: representing no mucus cell content, 2: one airway with PAS staining, 3: Multiple airways with strong PAS staining, 4: Multiple
airways with strong PAS staining and mucus filled airways. In addition, RNA was isolated from the lungs of control (Cont), RSV-infected (RSV), Flt3L
treated and RSV-infected (Flt3L+RSV) and Flt3L treated, pDC depleted, RSV infected (Flt3L+120G8+RSV) mice and transcribed into cDNA. Samples
were analyzed for Muc5ac and GOB-5 mRNA levels using quantitative real-time PCR by Taqman. Each sample was normalized using a GAPDH control
and the figure shows average fold increase to RNA obtained before infection6SEM. * P,0.05 compared to control mice, # P,0.05 compared to RSV
infected mice, n = 5–6 mice.
doi:10.1371/journal.pone.0001720.g004
pDC Dictates Immunity to RSV
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(Figure 5). The number of cDC remained elevated irrespective of
previous DC expansion. In the lymph nodes however, cDC
numbers were significantly higher in Flt3L and 120G8 treated
mice. The number of pDC was significantly higher in Flt3L
treated mice, which was significantly inhibited by earlier pDC
depletion. These data suggest that the initial expansion of pDC is
maintained in the lung and lung lymph nodes throughout infection
with RSV whereas the initial selective expansion of cDC is only
maintained in the lymph nodes. Therefore, it can be concluded
that a shift in the balance between cDC and pDC frequency is
maintained during a pulmonary infection and may be crucial for
the outcome of this infection.
Expansion of both cDC and pDC increases CD8+ T cell
responses to RSV, dependent on pDC
The alteration of the inflammatory response and immunopa-
thology has previously been linked to the nature of the T cell
activation [21]. To further define the responses after DC
expansion by Flt3L, T cell accumulation within the lungs was
characterized. Surprisingly, the number of total or activated
(CD69+) CD4+ T cells that were elicited to the lungs of RSV
infected mice did not change when cDC and pDC or cDC alone
were expanded before infection (Figure 6A, 6B). In contrast, the
number of CD8+ T cells was significantly increased in Flt3L
treated mice that was reduced again when the pDC were depleted
(Figure 6C, 6D). Furthermore, additional markers of CD8+ T cell
activation showed that expansion of cDC and pDC increased the
expression of IFN-c, assessed by intracellular staining, and
increased the percentage of RSV M2 protein specific pentamer
positive CD8+ T cells (Figure 6E, 6F). The increase in both of these
markers correlates nicely to the decreased pathology. Likewise, when
pDCs were depleted in these mice, there was a significant reduction
in those CD8 T cells that express IFN-c and stained positive with the
RSV M2 protein specific pentamer. Together, these studies indicate
that while expansion of DC had little effect on the number of CD4+
T cells, it significantly enhanced the CD8+ T cell numbers and CD8
effector response. This increased CD8 response was dependent upon
the increase in pDC.
Discussion
Previous studies have demonstrated the utility of using flt3 ligand
and described its function for enhancing the innate immune
responses through the expansion of DC subsets [10–12,22–25]. In
vitro it is known that flt3 ligand can induce the maturation of cDC,
but unlike GM-CSF also induces the differentiation of pDCs. The
present studies verify these observations by demonstrating expansion
of cDC and pDC in the lungs of naive animals treated with flt3
ligand. The objectives of these studies were to not only expand the
DC populations for enhanced anti-viral responses, but also to
examine whether the altered immune response was dependent upon
the pDC subset. Although the 120G8 did not completely remove all
pDCs, the treatment significantly reduced pDC numbers while
Figure 5. Selective expansion of cDC and pDC before RSV infection affects the number of cDC and pDC after RSV infection. Six days
after RSV infection, single cell suspensions of lungs and lung draining lymph nodes (LN) from control (Cont), RSV-infected (RSV), Flt3L treated and
RSV-infected (Flt3L+RSV) and Flt3L treated, pDC depleted, RSV infected (Flt3L+120G8+RSV) mice were analyzed by flow cytometry for the presence of
cDC (CD11chigh/CD11bhigh) or pDC (CD11c+/B220+). Results are displayed as precentage of total lung cells. * P,0.05 compared to non-infected
control mice, # P,0.05 compared to RSV infected mice, n = 3–6 mice per group.
doi:10.1371/journal.pone.0001720.g005
pDC Dictates Immunity to RSV
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allowing the increased numbers of cDC to be maintained and
respond to the virus infection. These data point out several
important aspects. Firstly, the results verify the importance of pDC
during viral infections for promoting the appropriate and non-
pathogenic responses. Secondly, it indicates that providing more
cDCs within the lung is not by itself sufficient for enhancing the anti-
viral responses. Thirdly, it suggests that pDC have a role in
enhancing CD8 T cell maturation and/or differentiation during the
viral responses. This latter issue may be both direct and indirect
through APC function and type I IFN production. While these
studies allow a better understanding of the relative role of the pDC
subset functions during RSV infection, they do not fully define how
the individual subsets contribute. In fact, numerous studies have
offered data suggesting that one important role of pDCs during anti-
viral or anti-tumor immunity may be for shaping the utility of the
cDC for proper APC function [7,8,26,27]. By examining the
cytokine profiles of the two DC subsets in response to RSV a picture
might be drawn on how these two subsets differentially contribute to
Figure 6. Selective expansion of cDC and pDC affects CD8+ T cell responses but not CD4+ T cell responses in the lung after RSV
infection. Six days after infection, single cell suspensions of lungs from control (Cont), RSV-infected (RSV), Flt3L treated and RSV-infected (Flt3L+RSV) and
Flt3L treated, pDC depleted, RSV infected (Flt3L+120G8+RSV) mice were analyzed by flow cytometry for the presence or expression of (A) CD3+CD4+ T
cells, (B) CD69 on CD4+ T cells, (C) CD3+CD8+ T cells, (D) CD69 on CD8+ T cells, (E) Intracellular IFN-c expression in CD8+ T cells or (F) RSV M2 MHCI
pentamer expression on CD8+ T cells. * P,0.05 compared to non-infected control mice, # P,0.05 compared to RSV infected mice, n= 4–6 mice per group.
doi:10.1371/journal.pone.0001720.g006
pDC Dictates Immunity to RSV
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the immune phenotype. While the cDC are capable of producing
significant levels of IL-12 that would enhance IFNc production from
T and NK cells, the pDC preferentially produces type I IFN that
may augment NK cell and CD8 T cell differentiation into a cytotoxic
phenotype [28]. Interestingly, our previous studies demonstrated
that depletion of pDC in normal mice led to an increase in IFNc
production, whereas in this study with Flt3L treatment the reduction
in pDC led to a decrease in IFNc. While we have not explored this
further, one explanation may be the relationship to the fluctuation in
the CD8 T cell population displayed in Figure 6 related to the Flt3L
treatment. Related to this latter issue, the observation that the RSV
infection significantly upregulated CD80 and CD86 expression on
the pDC may also contribute to this observation. A recent study
demonstrated using animals devoid of cDC subsets that pDC could
participate in APC function in lymph nodes for CD4 T cell
activation [29], a notion suggested by other previous studies in vitro
[30,31]. Together, this may suggest a direct or complimentary role
for pDC, along with the cDC, to function as APCs locally and/or in
the lymph node during RSV infection and enhance the anti-viral
responses, including IFNc production.
Classically, pDC are considered the primary source of IFN-a.
Although type I IFN can impact numerous cells involved in the
immune response [32–34], our previous reconstitution studies with
type I IFN after pDC depletion did not demonstrate an effect on
the nature of the immune response [14]. Other recent studies have
also indicated that cellular contact was necessary for pDC to
influence cDC ability to alter T cell responsiveness and soluble
factors were not sufficient [7]. Thus, we are presently considering a
reasonable model that includes both cDC and pDC interaction
with T cells in order to initiate the proper immune response. It is
unclear from our present data whether the altered CD8 T cell
responses are a direct result of reduced pDC participation or from
the altered CD4 T cell cytokine response that would normally
influence the differentiation of the cytotoxic T cells. Although it is
unclear what the necessary profile of molecules from pDC signal
cDC to instruct anti-viral T cell responses, they may include direct
interaction with the T cells via CD80 and CD86 upregulated on
pDC after RSV infection. Altogether, these data clearly demon-
strate the importance of pDC for directing the type of response to
RSV. Expansion of both pDC and cDC resulted in a decrease in
type 2, but an increase in type 1 T cell response to RSV and to a
general lower immunopathology after RSV infection. In contrast,
removal of pDC and expansion of only cDC significantly
enhanced Th2 type responses to RSV and led to more
inflammation and a higher airway response to RSV. As suggested
also by others [6], this demonstrates the highly immunogenic role
of cDC and the more regulatory role of pDC in the lung.
The coordination of the pulmonary immune response to a viral
infection appears to be primarily controlled in part by the presence
of the proper APC subsets. Previous studies have defined that
specific DC subsets can skew the immune response. Using defined
antigen models, early studies defined the nature of the local cDC
subset for preferential skewing toward Th2 responses [35–38].
However, these latter studies were performed in the absence of
pDC populations that were subsequently shown to regulate the
development of Th2 responses in lung [6]. The regulation and
coordination of the response by these two subsets may indeed
depend upon how they recognize a pathogen or antigen. The cDC
subset preferentially expresses a specific profile of TLRs that are
relevant to RSV infection, including TLR3 (dsRNA) and TLR4 (F
protein of RSV) [39,40]. In contrast, pDC preferentially expresses
TLR7 (ssRNA) that would promote type I IFN production [34]. In
our own studies with RSV we have found that in the absence of
TLR3 there is a skewed response toward increased IL-13 and
mucus overproduction, while deletion of MyD88 led to a fully Th2
skewed system that appeared to depend upon IL-12 and other
Th1-mediated responses associated with cDC populations [41,42].
Thus, multiple pathways and cell types are necessary for the most
appropriate non-pathogenic response in the lung. Altogether,
these studies represent additional evidence that the pDC
population can provide additional protection from adverse
pathologic outcomes and further support the use of Flt3 ligand
as an effective mediator to alter the pulmonary immune response.
Future vaccine strategies for RSV should focus on the role of
pDC during the immune response as well as a balance between
cDC and pDC in the lung and draining lymph nodes that seems to
be crucial for the outcome of a pulmonary infection. One
limitation of using Flt3L for expansion of pDC subsets during
specific diseases will be when and in what situations will it be most
relevant to use such a treatment modality. Finally, these studies
represent additional evidence that the pDC subset can initiate an
environment that is protected from adverse pathologic outcomes
during a pulmonary immune response.
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